(Q45360497)

13 December 2017

title

Role of neutralizing antibodies in adults with community-acquired pneumonia by respiratory syncytial virus (English)

1 reference

13 December 2017

1 reference

1 reference

Vivian Luchsinger

1

1 reference

13 December 2017

Pedro A Piedra

2

1 reference

13 December 2017

Mauricio Ruiz

3

1 reference

13 December 2017

Enna Zunino

4

1 reference

13 December 2017

María Angélica Martínez

5

1 reference

13 December 2017

Clarisse Machado

6

1 reference

13 December 2017

Rodrigo Fasce

7

1 reference

13 December 2017

María Teresa Ulloa

8

1 reference

13 December 2017

Maria Cristina Fink

9

1 reference

13 December 2017

Pamela Lara

10

1 reference

13 December 2017

Luis F Avendaño

11

1 reference

13 December 2017

language of work or name

English

0 references

publication date

11 January 2012

1 reference

Clinical Infectious Diseases

13 December 2017

published in

1 reference

13 December 2017

volume

54

1 reference

13 December 2017

issue

7

1 reference

13 December 2017

page(s)

905-912

1 reference

Epidemiology of community-acquired pneumonia in older adults: a population-based study

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR955

Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR955

Respiratory syncytial virus infection in elderly and high-risk adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR955

Incidence and characteristics of viral community-acquired pneumonia in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR955

Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR955

Diagnostic assays for respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR955

Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR955

Diagnosis of respiratory syncytial virus infection: comparison of reverse transcription-PCR to viral culture and serology in adults with respiratory illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR955

Risk factors for severe respiratory syncytial virus infection in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR955

A prediction rule to identify low-risk patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR955

Surveillance for Respiratory Syncytial Virus in Infants Hospitalized for Acute Lower Respiratory Infection in Chile (1989 to 2000)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR955

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR955

Molecular epidemiology of respiratory syncytial virus: rapid identification of subgroup A lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR955

Genetic variability of human metapneumovirus isolated from Chilean children, 2003-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR955

Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR955

Human metapneumovirus and respiratory syncytial virus infections in older children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR955

Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR955

Humoral immunity to respiratory syncytial virus in young and elderly adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR955

A flow cytometry-based assay to assess RSV-specific neutralizing antibody is reproducible, efficient and accurate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR955

Adenovirus surveillance on children hospitalized for acute lower respiratory infections in Chile (1988-1996)

21 January 2018

1 reference

12 December 2020

Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies

1 reference

12 December 2020

Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease

1 reference

12 December 2020

The role of viruses in the aetiology of community-acquired pneumonia in adults.

1 reference

12 December 2020

Enzyme-linked immunoassay for detection of PCR-amplified DNA of legionellae in bronchoalveolar fluid

1 reference

12 December 2020

Detection of rhinovirus in sinus brushings of patients with acute community-acquired sinusitis by reverse transcription-PCR.

1 reference

12 December 2020

Direct PCR enables detection of Mycoplasma pneumoniae in patients with respiratory tract infections

1 reference

12 December 2020

Respiratory syncytial virus infection in adults

1 reference

12 December 2020

1 reference

12 December 2020

Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis

1 reference

12 December 2020

Identifiers

DOI

10.1093/CID/CIR955

1 reference

13 December 2017

0 references

1 reference